Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
中國中藥(00570.HK)控股股東昨增持5,035萬股 均價1.86元

2025-04-09T  
中國中藥(00570.HK)委任副總裁

2025-03-26T  
《業績》中國中藥(00570.HK)全年純利5,407萬人民幣跌95.8% 連特別息派8.65港仙

2025-03-26T  
《大行》大摩降中國中藥(00570.HK)評級至「減持」 目標價下調至1.7元

2025-01-17T  
《港股》恆指高開168點 網易揚逾4% 紫金反彈近3%

2025-01-16T  
《盈警》中國中藥(00570.HK)估計全年溢利淨額大減90%-100%

2025-01-16T  
《大行》瑞銀:第十輪集採藥品降價幅度超預期 對中國仿製藥市場態度審慎

2024-12-19T  
野村料中國醫藥行業明年首季及上半年收入增速可回升

2024-12-12T  
內地第十批藥品集中採購即將開標 國採納入62種藥品

2024-12-12T  
內地計劃到2029年建成約1萬個中醫優勢專科

2024-12-12T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.